-
1دورية أكاديمية
المؤلفون: Bernklev, Linn, Nilsen, Jens Aksel, Augestad, Knut Magne, Holme, Øyvind, Pilonis, Nastazja Dagny
المصدر: In Best Practice & Research Clinical Gastroenterology February 2024 68
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
المؤلفون: Ree AH; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Høye E; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway., Esbensen Y; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway., Beitnes AR; Department of Pathology, Akershus University Hospital, Lørenskog, Norway., Negård A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Radiology, Akershus University Hospital, Lørenskog, Norway., Bernklev L; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Tetlie LK; Department of Oncology, Sørlandet Hospital, Kristiansand, Norway., Fretland ÅA; The Intervention Centre and Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway., Hamre HM; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Kersten C; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Department of Research, Sørlandet Hospital, Kristiansand, Norway., Hofsli E; Department of Oncology, St. Olav's Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Guren MG; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Nilsen HL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway.; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Flatmark K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway.; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway., Meltzer S; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
المصدر: Oncoimmunology [Oncoimmunology] 2024 Jun 28; Vol. 13 (1), pp. 2372886. Date of Electronic Publication: 2024 Jun 28 (Print Publication: 2024).
نوع المنشور: Journal Article; Case Reports; Randomized Controlled Trial
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
مواضيع طبية MeSH: Oxaliplatin*/therapeutic use , Oxaliplatin*/administration & dosage , Proto-Oncogene Proteins B-raf*/genetics , Proto-Oncogene Proteins B-raf*/antagonists & inhibitors , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Aged ; Mutation ; Microsatellite Instability/drug effects ; Treatment Outcome ; Aged, 80 and over